The Abuja Times

Nordica's Fibroid Centre Celebrates 1,000th HIFU Treatment Milestone

The Fibroid Care Centre at Nordica marks a significant achievement by completing its 1,000th High-Intensity Focused Ultrasound treatment for fibroids and adenomyosis. This milestone highlights the growing interest among Nigerian women for non-invasive alternatives to traditional surgical methods in managing fibroid-related health issues.

T

The Abuja Times

Sat, 3 Oct 2026• 2 min read
Nordica's Fibroid Centre Celebrates 1,000th HIFU Treatment Milestone
Nordica's Fibroid Centre Celebrates 1,000th HIFU Treatment Milestone — The Abuja Times Newsroom

The Fibroid Care Centre (FCC) at Nordica has reached a remarkable milestone by successfully completing its 1,000th High-Intensity Focused Ultrasound (HIFU) treatment within just five years of operation. This achievement underscores the centre's commitment to providing innovative fibroid care solutions and reflects a significant advancement in non-invasive medical technology in Nigeria.

Uterine fibroids, which are non-cancerous growths that can lead to severe symptoms such as heavy menstrual bleeding, pelvic pain, and abdominal enlargement, pose a considerable health challenge for many women in Nigeria. The FCC, recognized as West Africa's premier specialist centre for treating fibroids and adenomyosis, noted that there is a rising demand among patients for treatment options that minimize the need for invasive surgical procedures.

According to a statement from the FCC, the centre has become a beacon of hope for women seeking alternatives to traditional surgeries. One patient shared her positive experience, stating, "My recovery has brought noticeable changes to my menstrual cycle, with my bleeding reducing to five days and the blood clots and discomfort I previously experienced disappearing." Such testimonials highlight the effectiveness of HIFU treatments and the growing interest among women in exploring less invasive options.

The 1,000th treatment milestone is not just a number; it signifies a shift in how fibroid care is approached in Nigeria. As awareness of the availability and benefits of HIFU treatments increases, the FCC is poised to play a pivotal role in reshaping the narrative around women's health and fibroid management in the country.

Share this article with your network

Broadcast directly to WhatsApp communities and news circles.

Editorial Briefing

The Abuja Morning Dispatch

Get the capital's most important political investigations, cabinet decisions, and economic intelligence delivered to your inbox every morning.

No spam ever. Unsubscribe at any time with one click.

T

About The Abuja Times

Super Admin & Lead Director

Related Dispatches in Science & Tech

Bayelsa Introduces AI Robotic Tutors to Enhance Medical Education
Science & Tech
27 Oct•The Abuja Times

Bayelsa Introduces AI Robotic Tutors to Enhance Medical Education

In a groundbreaking initiative, the Bayelsa State government has unveiled AI robotic tutors at the state’s medical university, aiming to revolutionize medical training and research. This move underscores the government's commitment to integrating technology into education and improving healthcare outcomes in the region.

First Clinical Trial of Ebola Vaccine Launched in Democratic Republic of Congo
Science & Tech
24 Oct•The Abuja Times

First Clinical Trial of Ebola Vaccine Launched in Democratic Republic of Congo

The World Health Organization has initiated the first clinical trial of an Ebola vaccine amidst the ongoing outbreak in the Democratic Republic of Congo, which has claimed over 4,600 lives. The trial, named 'Tumaini,' aims to evaluate the effectiveness of the Ervebo vaccine against the Bundibugyo strain of the virus.

DR Congo Launches Hopeful Vaccine Trial Amidst Deadly Outbreak
Science & Tech
24 Oct•The Abuja Times

DR Congo Launches Hopeful Vaccine Trial Amidst Deadly Outbreak

The Democratic Republic of Congo has initiated a new vaccine trial named 'Tumaini' to combat the Bundibugyo virus, which has claimed over 4,600 lives. This trial represents a critical step in addressing the ongoing health crisis and developing effective preventive measures against the virus.